| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5943904 | Atherosclerosis | 2015 | 9 Pages |
Abstract
Our results reveal the pathways by which fenofibrate and gemfibrozil inhibit LPS-induced inflammatory activation of macrophages. This study elucidated a novel anti-inflammatory mechanism that acts through PPARα, β-defensin 1, and TLR4 pathways.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Soo-jin Ann, Ji Hyung Chung, Byung Hee Park, Soo Hyuk Kim, Jiyoung Jang, Sungha Park, Seok-Min Kang, Sang-Hak Lee,